arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Treace Medical Concepts, Inc.

TMCI Health Care Medical/Dental Instruments
$4.20
▲ +1.3% Today
as of Oct 23, 15:06 ET
Last 30 days -9.40% Sep 14 → Oct 23
$3.81 $4.03 $4.25 $4.47 $4.69 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$4.14
High
$4.30
Low
$4.14
Volume
$250,164
Avg Vol
$691,446
Mkt Cap
$253M
P/E (TTM)
—
Beta
—
52w High
$6.92
52w Low
$1.17
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 3 items

Sep 23 · 00:38 Insider Monkey
Treace Medical (TMCI) Reports Five-Year Bunion Results. Can Evidence Drive Adoption?
Sep 17 · 21:16 PR GlobeNewswire
Treace Announces Results of Three Clinical Studies Including the Milestone 5-Year ALIGN3D® Study Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure
Sep 15 · 21:06 PR GlobeNewswire
Treace Highlights Product Innovations and Clinical Data Across its Expanding Foot & Ankle Portfolio at the 2026 AOFAS Annual Meeting

TMCI earnings at a glance

Treace Medical Concepts, Inc. (TMCI) is scheduled to report earnings on Thursday, November 5, 2026 — in 13 days. Analysts expect earnings per share of -$0.25, compared with -$0.26 in the same quarter last year (+4%). The options market is pricing a move of about ±58.1% after the report, a range of roughly $1.76 to $6.64 from today's $4.20. Over its last 6 reports the stock rose the next day 3 times and fell 3, moving ±11.8% on average; after the most recent report on Aug 7, 2026 it moved +8.7%. That means options currently expect more movement than TMCI has typically delivered. TMCI beat the consensus EPS estimate in 6 of its last 6 reported quarters. Implied volatility is currently 492%. The share price of $4.20 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$1.17
$6.92
53% of range
Avg surprise (last 6)
+13.3%
Avg reaction (last 6)
-4.7%
50% positive
Latest IV / EM
492%
EM ±58.1% · $5 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.34$-0.29$-0.23$-0.17$-0.12 Actual $-0.23Actual $-0.20Actual $-0.28Actual $-0.30Actual $-0.34Actual $-0.25Actual $-0.25Est $-0.31Actual $-0.28Est $-0.29Actual $-0.26Est $-0.28Actual $-0.12Est $-0.15Actual $-0.28Est $-0.31Actual $-0.24Est $-0.30 MarJunSepMarJunSepMar/2025Jun/2025Sep/20258KMar/2026Jun/2026
Revenue vs Net Income Revenue Net income
$-18M$328,875$19M$37M$55M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Fri Aug 7, 2026Jun/2026 $-0.24 $-0.30 +20.0% -7.1% +8.7% earnings
Fri May 8, 2026Mar/2026 $-0.28 $-0.31 +9.7% -12.0% +4.7% earnings
Fri Feb 27, 20268K 2026-02-27 $-0.12 $-0.15 +20.0% — -11.4% earnings
Thu Nov 6, 2025Sep/2025 $-0.26 $-0.28 +7.1% — -28.3% earnings
Thu Aug 7, 2025Jun/2025 $-0.28 $-0.29 +3.5% — +7.9% earnings
Thu May 8, 2025Mar/2025 $-0.25 $-0.31 +19.4% — -9.5% earnings
Mon Sep 30, 2024Sep 2024 $-0.25 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.34 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.30 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.28 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.20 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.23 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Thu Nov 5, 2026Sep/2026OTHER -$0.25-$0.26 +3.9%

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$45M$47M—$50M$47M$53M—$45M
Cost of revenue$10M$10M—$11M$10M$11M—$9M
Gross profit$36M$37M—$40M$38M$42M—$36M
Operating income$-15M$-17M—$-16M$-17M$-16M—$-15M
Net income$-16M$-18M—$-16M$-17M$-16M—$-15M
EPS (diluted)$-0.24$-0.28—$-0.26$-0.28$-0.25—$-0.25

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$13M$10M$11M$8M$8M$13M$11M$12M
Inventory$40M$36M$36M$41M$42M$38M$39M$44M
Total current assets$120M$123M$132M$138M$148M$149M$161M$158M
Total assets$181M$184M$191M$197M$206M$206M$217M$213M
Long-term debt$56M$56M$56M$54M$53M$53M$53M$53M
Total liabilities$113M$107M$103M$107M$109M$101M$104M$108M
Total equity$68M$77M$87M$89M$98M$105M$113M$105M

Implied volatility — last 90 days

44%421%798%1175%1552% Jun 07 — IV 504% · EM ±69.8%Jun 08 — IV 472% · EM ±62.3%Jun 09 — IV 535% · EM ±67.0%Jun 10 — IV 474% · EM ±56.0%Jun 11 — IV 419% · EM ±46.2%Jun 12 — IV 470% · EM ±48.0%Jun 15 — IV 776% · EM ±56.1%Jun 16 — IV 884% · EM ±52.2%Jun 17 — IV 1553% · EM ±64.8%Jun 19 — IV 135% · EM ±29.8%Jun 22 — IV 152% · EM ±31.8%Jun 23 — IV 116% · EM ±23.8%Jun 24 — IV 160% · EM ±32.1%Jun 25 — IV 106% · EM ±20.8%Jun 26 — IV 132% · EM ±25.2%Jun 29 — IV 102% · EM ±18.1%Jun 30 — IV 446% · EM ±76.8%Jul 01 — IV 318% · EM ±53.2%Jul 02 — IV 228% · EM ±36.8%Jul 03 — IV 236% · EM ±36.8%Jul 06 — IV 269% · EM ±37.3%Jul 07 — IV 277% · EM ±36.6%Jul 08 — IV 494% · EM ±61.9%Jul 09 — IV 200% · EM ±23.6%Jul 10 — IV 68% · EM ±7.5%Jul 13 — IV 379% · EM ±31.7%Jul 14 — IV 342% · EM ±24.8%Jul 15 — IV 481% · EM ±28.4%Jul 16 — IV 622% · EM ±26.0%Jul 20 — IV 133% · EM ±31.3%Jul 21 — IV 145% · EM ±33.7%Jul 22 — IV 187% · EM ±42.9%Jul 23 — IV 302% · EM ±67.9%Jul 24 — IV 249% · EM ±55.0%Jul 27 — IV 176% · EM ±36.8%Jul 28 — IV 445% · EM ±91.0%Jul 29 — IV 321% · EM ±64.4%Jul 30 — IV 216% · EM ±42.2%Jul 31 — IV 227% · EM ±43.5%Aug 03 — IV 172% · EM ±30.4%Aug 04 — IV 147% · EM ±25.3%Aug 05 — IV 157% · EM ±26.2%Aug 07 — IV 140% · EM ±21.9%Aug 12 — IV 168% · EM ±21.1%Aug 24 — IV 82% · EM ±17.2%Aug 25 — IV 56% · EM ±11.4%Aug 26 — IV 77% · EM ±15.4%Aug 27 — IV 78% · EM ±15.2%Aug 28 — IV 79% · EM ±15.1%Aug 31 — IV 81% · EM ±14.4%Sep 01 — IV 44% · EM ±7.6%Sep 02 — IV 70% · EM ±11.7%Sep 03 — IV 63% · EM ±10.2%Sep 04 — IV 53% · EM ±8.3%Sep 07 — IV 60% · EM ±8.3%Sep 08 — IV 82% · EM ±10.8%Sep 10 — IV 243% · EM ±28.7%Sep 11 — IV 284% · EM ±31.4%Sep 15 — IV 287% · EM ±20.7%Sep 17 — IV 608% · EM ±25.4%Sep 21 — IV 104% · EM ±21.8%Sep 22 — IV 128% · EM ±26.1%Sep 23 — IV 116% · EM ±23.3%Sep 24 — IV 146% · EM ±28.6%Sep 28 — IV 145% · EM ±25.7%Oct 01 — IV 193% · EM ±31.2%Oct 06 — IV 331% · EM ±43.8%Oct 08 — IV 492% · EM ±58.1%

Sector peers

OSUR
OraSure Technologies, Inc.
$257M $4.12+6.9%
ANIK
Anika Therapeutics Inc.
$261M $21.32+3.5%
INFU
InfuSystems Holdings, Inc.
$265M $13.85-1.4%
UTMD
Utah Medical Products, Inc.
$234M $74.31-0.6%
PROF
Profound Medical Corp.
$214M $5.57-2.1%
PDEX
Pro-Dex, Inc.
$203M $61.62+1.8%

TMCI earnings FAQ

When is TMCI's next earnings date?

Treace Medical Concepts, Inc. is expected to report on November 5, 2026.

What is TMCI's expected move for earnings?

Options currently price a move of about ±58.1%, or $2.44 per share either way from $4.20.

How does TMCI stock usually react to earnings?

Across the last 6 reports the average next-day move was ±11.8%, up 3 times and down 3 times.

What EPS are analysts expecting from Treace Medical Concepts, Inc.?

The consensus estimate is -$0.25 per share, versus -$0.26 a year ago.

What is TMCI's implied volatility?

TMCI's at-the-money implied volatility is about 492% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in